These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 21503838)
1. Comparison of commercially available immunoblot assays measuring IgG and IgA antibodies to Bordetella pertussis antigens. Kennerknecht N; Riffelmann M; Schmetz J; Wirsing von König CH Eur J Clin Microbiol Infect Dis; 2011 Dec; 30(12):1531-5. PubMed ID: 21503838 [TBL] [Abstract][Full Text] [Related]
2. Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis. Riffelmann M; Thiel K; Schmetz J; Wirsing von Koenig CH J Clin Microbiol; 2010 Dec; 48(12):4459-63. PubMed ID: 20943873 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Western immunobloting to an enzyme-linked immunosorbent assay for the determination of anti-Bordetella pertussis antibodies. Merrigan SD; Welch RJ; Litwin CM Clin Vaccine Immunol; 2011 Apr; 18(4):615-20. PubMed ID: 21307277 [TBL] [Abstract][Full Text] [Related]
5. Assessment of IgA anti-PT and IgG anti-ACT reflex testing to improve Bordetella pertussis serodiagnosis in recently vaccinated subjects. Subissi L; Rodeghiero C; Martini H; Litzroth A; Huygen K; Leroux-Roels G; Piérard D; Desombere I Clin Microbiol Infect; 2020 May; 26(5):645.e1-645.e8. PubMed ID: 31610300 [TBL] [Abstract][Full Text] [Related]
6. Comparison of in-house enzyme-linked immunosorbent assay (ELISA) and six commercial ELISAs for Detection of antibodies to Bordetella pertussis. Rastawicki W J Microbiol Methods; 2024 Sep; 224():107011. PubMed ID: 39111714 [TBL] [Abstract][Full Text] [Related]
7. [Diagnostic value of IgG, IgA, and IgM to Bordetella pertussis antigens in patients with pertussis]. Zaĭtsev EM; Mazurova IL; Petrova MS; Krasnoproshina LI; Zakharova NS Zh Mikrobiol Epidemiol Immunobiol; 2008; (6):23-6. PubMed ID: 19186540 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of Commercial Assays for Single-Point Diagnosis of Pertussis in the US. Pawloski LC; Plikaytis BD; Martin MD; Martin SW; Prince HE; Lapé-Nixon M; Tondella ML J Pediatric Infect Dis Soc; 2017 Sep; 6(3):e15-e21. PubMed ID: 27451419 [TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of an Australian pertussis toxin IgG and IgA enzyme immunoassay. May ML; Doi SA; King D; Evans J; Robson JM Clin Vaccine Immunol; 2012 Feb; 19(2):190-7. PubMed ID: 22131356 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies. Prince HE; Lapé-Nixon M; Matud J Clin Vaccine Immunol; 2006 Feb; 13(2):266-70. PubMed ID: 16467336 [TBL] [Abstract][Full Text] [Related]
11. Characterization of serological responses to pertussis. Watanabe M; Connelly B; Weiss AA Clin Vaccine Immunol; 2006 Mar; 13(3):341-8. PubMed ID: 16522775 [TBL] [Abstract][Full Text] [Related]
12. Antibody Specificity Following a Recent Raeven RHM; van der Maas L; Pennings JLA; Fuursted K; Jørgensen CS; van Riet E; Metz B; Kersten GFA; Dalby T Front Immunol; 2019; 10():1364. PubMed ID: 31275314 [No Abstract] [Full Text] [Related]
13. Development and validation of an Australian in-house anti-pertussis toxin IgG and IgA enzyme immunoassay. May ML; Evans J; Riley J; Lambkin G; Robson JM Pathology; 2013 Feb; 45(2):172-80. PubMed ID: 23250035 [TBL] [Abstract][Full Text] [Related]
14. Comparison of five commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis. Kösters K; Riffelmann M; Dohrn B; von König CH Clin Diagn Lab Immunol; 2000 May; 7(3):422-6. PubMed ID: 10799456 [TBL] [Abstract][Full Text] [Related]
15. Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study. Xing D; Wirsing von König CH; Newland P; Riffelmann M; Meade BD; Corbel M; Gaines-Das R Clin Vaccine Immunol; 2009 Mar; 16(3):303-11. PubMed ID: 19109448 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of serology and nasopharyngeal cultures for diagnosis of pertussis in a vaccine efficacy trial. Hallander HO; Storsaeter J; Möllby R J Infect Dis; 1991 May; 163(5):1046-54. PubMed ID: 2019753 [TBL] [Abstract][Full Text] [Related]
17. External quality assessment of pertussis serology in Germany. Riffelmann M; Hunfeld KP; Müller I; Xing D; Kennerknecht N; Wirsing von König CH Eur J Clin Microbiol Infect Dis; 2013 Mar; 32(3):421-3. PubMed ID: 23076769 [TBL] [Abstract][Full Text] [Related]
18. Evidence of Bordetella pertussis infection in vaccinated 1-year-old Danish children. von Linstow ML; Pontoppidan PL; von König CH; Cherry JD; Hogh B Eur J Pediatr; 2010 Sep; 169(9):1119-22. PubMed ID: 20373111 [TBL] [Abstract][Full Text] [Related]
19. Improvement in serological diagnosis of pertussis by external quality assessment. Markey K; Douglas-Bardsley A; Asokanathan C; Fry NK; Barkoff AM; Bacci S; Ködmön C; He Q J Med Microbiol; 2019 May; 68(5):741-747. PubMed ID: 30990403 [TBL] [Abstract][Full Text] [Related]
20. Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay. Fry NK; Litt DJ; Duncan J; Vaghji L; Warrener L; Samuel D; Andrews N; Harnden A; Harrison TG J Med Microbiol; 2013 Sep; 62(Pt 9):1281-1289. PubMed ID: 23722435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]